Current Protein Identity:Q2N0S6 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
3J5M Cryo-EM structure of the BG505 SOSIP.664 HIV-1 Env trimer with 3 PGV04 Fabs Deposited 2013-10-26 Assembly 1 Protein heterocomplex Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–504(475 aa) Fragment:UNP residues 30-504
Chain E 30–504(475 aa) Fragment:UNP residues 30-504
Chain I 30–504(475 aa) Fragment:UNP residues 30-504
Mutation:T332N,A501C Mutation:T332N,A501C Mutation:T332N,A501C No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer TBS;pH 7.5;TBS
cryo-EM vitrification conditions Specimen was prepared for cryo-EM by applying 3 microliters of sample to a freshly plasma cleaned holey carbon C-flat grid (Protochips, Inc.), allowing the sample to adsorb to the grid for 30 seconds, followed by blotting with a small piece of filter paper and plunge-freezing into liquid ethane using a manual cryo-plunger in an ambient environment (4 C).;Cryogen ETHANE;3 uL sample applied to grid, adsorbed for 30 seconds, blotted, and plunge-frozen in liquid ethane
Resolution 5.80 Å
4NCO Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with the Broadly Neutralizing Fab PGT122 Deposited 2013-10-24 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–504(475 aa) Fragment:UNP residues 30-504
Chain E 30–504(475 aa) Fragment:UNP residues 30-504
Chain I 30–504(475 aa) Fragment:UNP residues 30-504
Mutation:T332N,A501C Mutation:T332N,A501C Mutation:T332N,A501C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 30 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 10.5;293 K;0.1 M CAPS, 2 M ammonium sulfate, 0.2 M lithium sulfate, pH 10.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
Resolution 4.70 Å R-free 0.389
4ZMJ Crystal Structure of Ligand-Free BG505 SOSIP.664 HIV-1 Env Trimer Deposited 2015-05-04 Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain B 509–661(153 aa)
Chain G 30–504(475 aa)
Mutation:I559P, T605C Mutation:T332N, A501C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 45 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;26% PEG 400, 3.2% PEG 3350, and 0.1M sodium acetate pH 5.5
Resolution 3.31 Å R-free 0.285
5ACO Cryo-EM structure of PGT128 Fab in complex with BG505 SOSIP.664 Env trimer Deposited 2015-08-17 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–505(476 aa) Fragment:GP120, RESIDUES 30-505
Chain B 509–661(153 aa) Fragment:GP41, RESIDUES 509-661
Chain C 30–505(476 aa) Fragment:GP120, RESIDUES 30-505
Chain D 30–505(476 aa) Fragment:GP120, RESIDUES 30-505
Chain E 509–661(153 aa) Fragment:GP41, RESIDUES 509-661
Chain F 509–661(153 aa) Fragment:GP41, RESIDUES 509-661
Mutation:YES Mutation:YES Mutation:YES Mutation:YES Mutation:YES Mutation:YES NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 ELECTRON MICROSCOPY
cryo-EM buffer 50 MM TRIS, 150 MM NACL, 0.675 MM DDM;pH 7.4;50 MM TRIS, 150 MM NACL, 0.675 MM DDM
cryo-EM vitrification conditions Cryogen ETHANE;FROZEN IN LIQUID ETHANE AT 4 DEGREES C.
Resolution 4.36 Å
5C7K Crystal structure BG505 SOSIP gp140 HIV-1 Env trimer bound to broadly neutralizing antibodies PGT128 and 8ANC195 Deposited 2015-06-24 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain C 30–507(478 aa) Fragment:UNP Residues 30-507
Chain D 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;280 K;0.05 M lithium sulfate, 0.05 M sodium sulfate, 26% (w/v) PEG 400 and 0.1 M Tris-HCl pH 8.3
Resolution 4.60 Å R-free 0.295
5CEZ Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with an early putative precursor of the PGT121 family at 3.0 Angstrom Deposited 2015-07-08 Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain G 31–508(478 aa) Fragment:UNP residues 31-505
Mutation:N137A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 MAN alpha-D-mannopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277.15 K;0.2 M CaCl2, 28% (v/v) PEG 400 and 0.1 M Hepes pH 7.5
Resolution 3.03 Å R-free 0.266
5CEZ Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with an early putative precursor of the PGT121 family at 3.0 Angstrom Deposited 2015-07-08 Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 MAN alpha-D-mannopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277.15 K;0.2 M CaCl2, 28% (v/v) PEG 400 and 0.1 M Hepes pH 7.5
Resolution 3.03 Å R-free 0.266
5CJX Crystal structure of 8ANC195 Fab in complex with BG505 SOSIP.664 HIV-1 Env trimer Deposited 2015-07-15 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain G 32–505(474 aa) Fragment:UNP residues 32-505
Chain J 509–661(153 aa) Fragment:UNP residues 509-661
Chain K 32–505(474 aa) Fragment:UNP residues 32-505
Chain X 509–661(153 aa) Fragment:UNP residues 509-661
Chain Y 32–505(474 aa) Fragment:UNP residues 32-505
Mutation:I559P, T605C Mutation:T332N, A501C Mutation:I559P, T605C Mutation:T332N, A501C Mutation:I559P, T605C Mutation:T332N, A501C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 8;298 K;0.1 M Tris, pH 8.0, 15% PEG3350, 2% v/v 1,4-dioxane
Resolution 3.58 Å R-free 0.286
5D9Q Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with the Broadly Neutralizing Fab PGT122 and scFv NIH45-46 Deposited 2015-08-18 Assembly 1 Other combination Heteromer;Protein × 15 PDB declaration: pentadecameric(15) Consistent with protein count
Chain A 30–501(472 aa)
Chain G 30–501(472 aa)
Chain J 30–501(472 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;2.4 M ammonium sulfate, 0.1 M Tris, pH 8.0
Resolution 4.40 Å R-free 0.320
5FYL Crystal Structure at 3.7 A Resolution of Fully Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env Trimer in Complex with Broadly Neutralizing Antibodies PGT122 and 35O22 Deposited 2016-03-08 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain B 509–661(153 aa) Fragment:GP120 ENV ECTODOMAIN
Chain G 30–505(476 aa) Fragment:GP120 ENV ECTODOMAIN
Mutation:YES Mutation:YES NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5;0.18 M LI2SO4, 4.79% PEG 1500, 14.4% ISOPROPANOL, 10 MM YTTRIUM CHLORIDE, 0.09 M SODIUM ACETATE PH 5.5
Resolution 3.10 Å R-free 0.307
5I8H Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer in Complex with V3 Loop-targeting Antibody PGT122 Fab and Fusion Peptide-targeting Antibody VRC34.01 Fab Deposited 2016-02-18 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain A 30–508(479 aa)
Chain B 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 24 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0.5M Sodium Chloride, 0.1M Tris-HCl pH8.5, 5% PEG 8000 and 20% 2-methyl-2, 4- pentanediol
Resolution 4.30 Å R-free 0.309
5I8H Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer in Complex with V3 Loop-targeting Antibody PGT122 Fab and Fusion Peptide-targeting Antibody VRC34.01 Fab Deposited 2016-02-18 Assembly 2 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain C 30–508(479 aa)
Chain D 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 24 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0.5M Sodium Chloride, 0.1M Tris-HCl pH8.5, 5% PEG 8000 and 20% 2-methyl-2, 4- pentanediol
Resolution 4.30 Å R-free 0.309
5T3S HIV gp140 trimer MD39-10MUTA in complex with Fabs PGT124 and 35022 Deposited 2016-08-26 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain B 509–661(153 aa)
Chain G 30–505(476 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 21 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 4.1;277 K;5% Peg6000 0.1M citric acid
Resolution 4.50 Å R-free 0.309
5T3X 3.9 Angstrom Crystal Structure of a Fully and Natively Glycosylated BG505 SOSIP.664 HIV-1 Env Trimer in Complex with the Broadly Neutralizing Antibodies IOMA and 10-1074. Deposited 2016-08-26 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain B 509–661(153 aa) Fragment:UNP residues 509-611
Chain G 30–508(479 aa) Fragment:UNP residues 30-508
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;200 mM ammonium citrate tribasic pH 7.0 100 mM imidazole pH 7.0 20% PEG MME 2,000
Resolution 3.90 Å R-free 0.331
5T3Z 3.5 Angstrom Crystal Structure of a Fully and Natively Glycosylated BG505 SOSIP.664 HIV-1 Env Trimer in Complex with the Broadly Neutralizing Antibodies IOMA and 10-1074 Deposited 2016-08-26 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain B 509–661(153 aa) Fragment:UNP residues 509-611
Chain G 30–508(479 aa) Fragment:UNP residues 30-508
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;200 mM ammonium citrate tribasic pH 7.0 100 mM imidazole pH 7.0 20% PEG MME 2,000
Resolution 3.50 Å R-free 0.306
5THR Cryo-EM structure of a BG505 Env-sCD4-17b-8ANC195 complex Deposited 2016-09-30 Assembly 1 Other combination Heteromer;Protein × 21 PDB declaration: 21-meric(21) Consistent with protein count
Chain A 509–661(153 aa) Fragment:UNP residues 509-661
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain C 509–661(153 aa) Fragment:UNP residues 509-661
Chain D 30–505(476 aa) Fragment:UNP residue 30-505
Chain E 30–505(476 aa) Fragment:UNP residue 30-505
Chain F 30–505(476 aa) Fragment:UNP residue 30-505
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE-PROPANE
Resolution 8.90 Å
5U1F Initial contact of HIV-1 Env with CD4: Cryo-EM structure of BG505 DS-SOSIP trimer in complex with CD4 and antibody PGT145 Deposited 2016-11-28 Assembly 1 Protein heterocomplex Heteromer;Protein × 9 PDB declaration: nonameric(9) Consistent with protein count
Chain A 29–502(474 aa) Fragment:UNP residues 29-502
Chain B 508–661(154 aa)
Chain C 29–502(474 aa) Fragment:UNP residues 29-502
Chain D 29–502(474 aa) Fragment:UNP residues 29-502
Chain E 508–661(154 aa)
Chain F 508–661(154 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 6.80 Å
5UTF Crystal Structure of a Stabilized DS-SOSIP.6mut BG505 gp140 HIV-1 Env Trimer, Containing Mutations I201C-P433C (DS), L154M, Y177W, N300M, N302M, T320L, I420M in Complex with Human Antibodies PGT122 and 35O22 at 4.3 A Deposited 2017-02-14 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain B 509–661(153 aa)
Chain G 30–510(481 aa)
Mutation:I201C-P433C (DS) Mutation:L154M, Y177W, N300M, N302M, T320L, I420M NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 21 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;13.2% PEG 400, 6.6% PEG 8000, 0.1M. Sodium acetate/Acetic acid pH 4.5
Resolution 3.50 Å R-free 0.299
5UTY Crystal Structure of a Stabilized DS-SOSIP.mut4 BG505 gp140 HIV-1 Env Trimer, Containing Mutations I201C-P433C (DS), L154M, N300M, N302M, T320L in Complex with Human Antibodies PGT122 and 35O22 at 4.1 Angstrom Deposited 2017-02-15 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain G 29–505(477 aa) Fragment:UNP residues 29-505
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 24 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.6;293 K;10.5% PEG 4000, 0.2M AmSO4, 0.1M NaoAc pH 4.6
Resolution 3.41 Å R-free 0.288
5V7J Crystal Structure at 3.7 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env Trimer with Four Glycans (N197, N276, N362, and N462) removed in Complex with Neutralizing Antibodies 3H+109L and 35O22. Deposited 2017-03-20 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain G 31–505(475 aa) Fragment:UNP residues 31-505
Mutation:S198A, T278A, S365A, T464A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;294 K;4.95% isopropanol, 8.25% PEG 3350, 0.2M ammonium citrate, pH 4.5
Resolution 2.91 Å R-free 0.339
5V8L BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibodies 3BNC117 and PGT145 Deposited 2017-03-22 Assembly 1 Other combination Heteromer;Protein × 14 PDB declaration: tetradecameric(14) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain C 30–505(476 aa) Fragment:UNP residues 30-505
Chain D 30–505(476 aa) Fragment:UNP residues 30-505
Chain E 509–661(153 aa) Fragment:UNP residues 509-661
Chain F 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 20 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.30 Å
5V8M BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibody 3BNC117 Deposited 2017-03-22 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain F 30–505(476 aa) Fragment:UNP residues 30-505
Chain G 30–505(476 aa) Fragment:UNP residues 30-505
Chain I 509–661(153 aa) Fragment:UNP residues 509-661
Chain J 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 21 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.40 Å
5VIY BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Deposited 2017-04-17 Assembly 1 Other combination Heteromer;Protein × 16 PDB declaration: hexadecameric(16) Consistent with protein count
Chain A 509–661(153 aa) Fragment:UNP residues 509-661
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain C 509–661(153 aa) Fragment:UNP residues 509-661
Chain D 30–508(479 aa) Fragment:UNP residues 30-505
Chain E 30–508(479 aa) Fragment:UNP residues 30-505
Chain F 30–508(479 aa) Fragment:UNP residues 30-505
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 13 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE-PROPANE
Resolution 6.20 Å
5VJ6 BG505 SOSIP.664 in complex with broadly neutralizing antibodies PG9 and 8ANC195 Deposited 2017-04-18 Assembly 1 Protein heterocomplex Heteromer;Protein × 14 PDB declaration: tetradecameric(14) Consistent with protein count
Chain A 509–661(153 aa) Fragment:UNP residues 509-661
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain C 509–661(153 aa) Fragment:UNP residues 509-661
Chain D 30–505(476 aa) Fragment:UNP residues 30-505
Chain E 30–505(476 aa) Fragment:UNP residues 30-505
Chain F 30–505(476 aa) Fragment:UNP residues 30-505
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE-PROPANE
Resolution 11.50 Å
5W6D Crystal structure of BG505-SOSIP.v4.1-GT1-N137A in complex with Fabs 35022 and 9H/109L Deposited 2017-06-16 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain B 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 4.5;277 K;0.2M NaCl, 34% PEG 300, 0.1M NaOAc
Resolution 3.20 Å R-free 0.267
5WDU HIV-1 Env BG505 SOSIP.664 H72C-H564C trimer in complex with bNAbs PGT122 Fab, 35O22 Fab and NIH45-46 scFv Deposited 2017-07-06 Assembly 1 Other combination Heteromer;Protein × 21 PDB declaration: 21-meric(21) Consistent with protein count
Chain F 31–501(471 aa)
Chain G 31–501(471 aa)
Chain Q 31–501(471 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 33 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;8% (w/v) polyethylene glycol 8000, 0.1 M Tris, pH 8.5
Resolution 7.00 Å R-free 0.363
6B0N Crystal structure of the cleavage-independent prefusion HIV Env glycoprotein trimer of the clade A BG505 isolate (NFL construct) in complex with Fabs PGT122 and PGV19 at 3.39 A Deposited 2017-09-14 Assembly 1 Insufficient information Heteromer;Protein × 15 PDB declaration: pentadecameric(15) Consistent with protein count
Chain G 30–503(474 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 36 MAN alpha-D-mannopyranose × 6 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293.15 K;0.1M HEPES (pH 7.0), 15% (w/v) PEG4000, and cryo-protected with 25% glycerol
Resolution 3.40 Å R-free 0.346
6CH7 XFEL crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 Deposited 2018-02-22 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain G 30–508(479 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;5% Tacismate pH 8.0, 14% PEG 3350, 0.1M Tris pH 8.0
Resolution 3.80 Å R-free 0.262
6CH8 Crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 Deposited 2018-02-22 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain G 30–508(479 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;5% Tacismate pH 8.0, 15% PEG 3350
Resolution 4.10 Å R-free 0.274
6CHB Crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and IOMA Deposited 2018-02-22 Assembly 1 Protein heterocomplex Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain F 30–508(479 aa)
Chain G 30–508(479 aa)
Chain H 30–508(479 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;5% Tacismate pH 8.0, 15% PEG 3350
Resolution 6.80 Å R-free 0.417
6CUE Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody vFP7.04 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 Deposited 2018-03-26 Assembly 1 Other combination Heteromer;Protein × 24 PDB declaration: 24-meric(24) Consistent with protein count
Chain 2 30–502(473 aa)
Chain C 30–502(473 aa)
Chain c 30–502(473 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.00 Å
6CUF Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody vFP1.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 Deposited 2018-03-26 Assembly 1 Other combination Heteromer;Protein × 24 PDB declaration: 24-meric(24) Consistent with protein count
Chain 2 30–502(473 aa)
Chain C 30–502(473 aa)
Chain d 30–502(473 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.00 Å
6DE7 Crystal Structure at 4.3 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env Trimer with Interdomain Stabilization 113C-429GCG in Complex with Broadly Neutralizing Antibodies PGT122 and 35O22 Deposited 2018-05-11 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain G 30–510(481 aa)
Mutation:D113C, T332N, R429G, A501C, E509R, K510R, A512R, V513R NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 5.5;293 K;24%PEG400, 3% PEG3350, 0.1M sodium acetate 5.5, 0.2M LiSO4
Resolution 4.12 Å R-free 0.258
6DFG BG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen binding Deposited 2018-05-14 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–505(476 aa)
Chain C 30–505(476 aa)
Chain D 30–505(476 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE;3.5 second blot time
Resolution 4.42 Å
6DFH BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding Deposited 2018-05-14 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–505(476 aa)
Chain C 30–505(476 aa)
Chain D 30–505(476 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE;5 second blot time
Resolution 3.85 Å
6DID HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 Deposited 2018-05-23 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–505(476 aa) Fragment:GP120 domain residues 30-505
Chain F 30–505(476 aa) Fragment:GP120 domain residues 30-505
Chain G 30–505(476 aa) Fragment:GP120 domain residues 30-505
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 21 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.71 Å
6E5P Backbone model based on cryo-EM map at 8.5 A of domain-swapped, glycan-reactive, neutralizing antibody 2G12 bound to HIV-1 Env BG505 DS-SOSIP, which was also bound to CD4-binding site antibody VRC03 Deposited 2018-07-21 Assembly 1 Other combination Heteromer;Protein × 24 PDB declaration: 24-meric(24) Consistent with protein count
Chain A 30–503(474 aa)
Chain C 30–503(474 aa)
Chain E 30–503(474 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.01
cryo-EM vitrification conditions Cryogen ETHANE;0.005% dodecyl maltoside was added to sample before vitification
Resolution 8.80 Å
6MAR HIV-1 Envelope Glycoprotein Clone BG505 delCT N332T in complex with broadly neutralizing antibody Fab PGT151 Deposited 2018-08-28 Assembly 1 Other combination Heteromer;Protein × 10 PDB declaration: decameric(10) Consistent with protein count
Chain A 30–502(473 aa)
Chain C 30–502(473 aa)
Chain E 30–502(473 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 22 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.50 Å
6MN7 Cryo-EM structure of BG505.SOSIP.664 in complex with BF520.1 antigen binding fragment Deposited 2018-10-01 Assembly 1 Other combination Heteromer;Protein × 9 PDB declaration: nonameric(9) Consistent with protein count
Chain A 30–505(476 aa)
Chain C 30–505(476 aa)
Chain D 30–505(476 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.80 Å
6MPG Cryo-EM structure at 3.2 A resolution of HIV-1 fusion peptide-directed antibody, A12V163-b.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 Deposited 2018-10-06 Assembly 1 Other combination Heteromer;Protein × 24 PDB declaration: 24-meric(24) Consistent with protein count
Chain 2 30–502(473 aa)
Chain C 30–502(473 aa)
Chain V 30–502(473 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
6MPH Cryo-EM structure at 3.8 A resolution of HIV-1 fusion peptide-directed antibody, DF1W-a.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 Deposited 2018-10-06 Assembly 1 Other combination Heteromer;Protein × 24 PDB declaration: 24-meric(24) Consistent with protein count
Chain A 30–502(473 aa)
Chain B 30–502(473 aa)
Chain C 30–502(473 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.80 Å
6MTJ Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-378806 in Complex with Human Antibodies 3H109L and 35O22 at 2.9 Angstrom Deposited 2018-10-19 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain B 509–661(153 aa) Fragment:gp41
Chain G 30–505(476 aa) Fragment:gp120
Mutation:I559P, A605C Mutation:N137A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 36 83G 1-[(2R)-4-(benzenecarbonyl)-2-methylpiperazin-1-yl]-2-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)ethane-1,2-dione × 3 X-RAY DIFFRACTION
X-ray crystallization conditions EVAPORATION;298 K;75mM Imidazole pH6.5 3.75% MPD 6.25% PEG 3,350 150mM LiSO4
Resolution 2.34 Å R-free 0.281
6MTN Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor Compound 484 in Complex with Human Antibodies 3H109L and 35O22 at 3.0 Angstrom Deposited 2018-10-20 Assembly 1 Other combination Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain B 509–661(153 aa) Fragment:gp41
Chain G 30–505(476 aa) Fragment:gp120
Mutation:I559P, A605C Mutation:N137A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 11 JYJ {4-[1-(3-chlorophenyl)cyclopropane-1-carbonyl]piperazin-1-yl}(thiophen-3-yl)methanone × 1 X-RAY DIFFRACTION
X-ray crystallization conditions EVAPORATION;298 K;60mM Imidazole pH6.5 3% MPD 5% PEG3,350 120mM LiSO$
Resolution 2.50 Å R-free 0.263
6MU6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-814508 in Complex with Human Antibodies 3H109L and 35O22 at 3.2 Angstrom Deposited 2018-10-22 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain B 509–661(153 aa) Fragment:gp41
Chain G 30–505(476 aa) Fragment:gp120
Mutation:I559P, A605C Mutation:N137A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 30 JYV (2R)-{1-[{7-[2-({[3-(dimethylamino)propyl](methyl)amino}methyl)-1,3-thiazol-4-yl]-4-methoxy-1H-pyrrolo[2,3-c]pyridin-3-yl}(oxo)acetyl]piperidin-4-yl}(phenyl)acetonitrile × 3 X-RAY DIFFRACTION
X-ray crystallization conditions EVAPORATION;298 K;60mM imidazole pH6.5 3% MPD 5% PEG3,350 120mM LiSO4
Resolution 2.55 Å R-free 0.264
6MU7 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-818251 in Complex with Human Antibodies 3H109L and 35O22 at 3.1 Angstrom Deposited 2018-10-22 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain B 509–661(153 aa) Fragment:gp41
Chain G 30–505(476 aa) Fragment:gp120
Mutation:I559P, A605C Mutation:N137A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 36 JYY 4-{3-[{4-[(R)-cyano(phenyl)methyl]piperidin-1-yl}(oxo)acetyl]-4-methoxy-1H-pyrrolo[2,3-c]pyridin-7-yl}-N-(2-hydroxyethyl)-1,3-thiazole-2-carboxamide × 3 X-RAY DIFFRACTION
X-ray crystallization conditions EVAPORATION;298 K;150mM Ammonium Citrate pH7.5 7.5% PEG3,350 7.5% isopropanol
Resolution 2.50 Å R-free 0.261
6MU8 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.5 Angstrom Deposited 2018-10-22 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain B 509–661(153 aa) Fragment:gp41
Chain G 30–505(476 aa) Fragment:gp120
Mutation:I559P, A605C Mutation:N137A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 33 JYS 1-[4-(benzenecarbonyl)piperazin-1-yl]-2-(4-bromo-7-fluoro-1H-indol-3-yl)ethane-1,2-dione × 3 X-RAY DIFFRACTION
X-ray crystallization conditions EVAPORATION;298 K;60mM imidazole pH6.5 3% MPD 5% PEG3,350 120mM LiSO4
Resolution 2.99 Å R-free 0.259
6N1V Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody A12V163-a.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 Deposited 2018-11-12 Assembly 1 Other combination Heteromer;Protein × 24 PDB declaration: 24-meric(24) Consistent with protein count
Chain A 30–502(473 aa)
Chain B 30–502(473 aa)
Chain C 30–502(473 aa)
Chain D 509–661(153 aa)
Chain E 509–661(153 aa)
Chain F 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.00 Å
6N1W Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 Deposited 2018-11-12 Assembly 1 Other combination Heteromer;Protein × 24 PDB declaration: 24-meric(24) Consistent with protein count
Chain 2 30–502(473 aa)
Chain C 30–502(473 aa)
Chain c 30–502(473 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.20 Å
6NF2 Cryo-EM structure of vaccine-elicited antibody 0PV-c.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122 Deposited 2018-12-18 Assembly 1 Other combination Heteromer;Protein × 24 PDB declaration: 24-meric(24) Consistent with protein count
Chain A 30–509(480 aa)
Chain B 509–661(153 aa)
Chain G 30–509(480 aa)
Chain I 509–661(153 aa)
Chain Q 30–509(480 aa)
Chain R 509–661(153 aa)
Mutation:I201C, T332N, A433C, A501C, E509R, K510R, A512R Mutation:I559P, T605C Mutation:I201C, T332N, A433C, A501C, E509R, K510R, A512R Mutation:I559P, T605C Mutation:I201C, T332N, A433C, A501C, E509R, K510R, A512R Mutation:I559P, T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.70 Å
6NM6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to N6 FR3-03 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.2 Angstrom Deposited 2019-01-10 Assembly 1 Other combination Heteromer;Protein × 24 PDB declaration: 24-meric(24) Consistent with protein count
Chain B 509–661(153 aa) Fragment:Ectodomain
Chain G 30–505(476 aa)
Mutation:I559P, T605C Mutation:N137A, T332N, A501C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 21 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;298 K;60 mM acetate pH 4.5, 420 mM sodium formate, 5% PEG 3,350 and 60 mM CaCl2
Resolution 2.74 Å R-free 0.288
6NNF Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to VRC01 FR3-03 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.5 Angstrom Deposited 2019-01-14 Assembly 1 Other combination Heteromer;Protein × 24 PDB declaration: 24-meric(24) Consistent with protein count
Chain B 509–661(153 aa) Fragment:gp41
Chain G 30–505(476 aa) Fragment:gp120
Mutation:I559P, A605C Mutation:N137A, T332N, A501C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 15 X-RAY DIFFRACTION
X-ray crystallization conditions EVAPORATION;298 K;72 mM imidazole pH 6.5, 72 mM
Resolution 2.76 Å R-free 0.298
6NNJ Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to CH31 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.1 Angstrom Deposited 2019-01-15 Assembly 1 Other combination Heteromer;Protein × 24 PDB declaration: 24-meric(24) Consistent with protein count
Chain B 509–661(153 aa) Fragment:gp41
Chain G 30–505(476 aa) Fragment:gp120
Mutation:I559P, A605C Mutation:N137A, T332N, A501C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 21 X-RAY DIFFRACTION
X-ray crystallization conditions EVAPORATION;298 K;90 mM imidazole pH 6.5, 90 mM MgCl2, 0.6 M NaCl and 6% PEG 3,350
Resolution 2.60 Å R-free 0.293
6OPA Crystal structure of bovine Fab NC-Cow1 in complex with HIV-1 BG505 SOSIP.664, and human Fabs 35022 and PGT128 Deposited 2019-04-24 Assembly 1 Other combination Heteromer;Protein × 24 PDB declaration: 24-meric(24) Consistent with protein count
Chain B 509–661(153 aa)
Chain G 30–504(475 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8.56;298 K;0.2M sodium citrate, 0.1M Tris, 30% Peg400
Resolution 4.08 Å R-free 0.343
6OSY Cryo-EM structure of vaccine-elicited antibody 0PV-a.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122 Deposited 2019-05-02 Assembly 1 Other combination Heteromer;Protein × 24 PDB declaration: 24-meric(24) Consistent with protein count
Chain 2 30–508(479 aa)
Chain B 30–508(479 aa)
Chain K 30–508(479 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.30 Å
6OT1 Cryo-EM structure of vaccine-elicited antibody 0PV-b.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122 Deposited 2019-05-02 Assembly 1 Other combination Heteromer;Protein × 24 PDB declaration: 24-meric(24) Consistent with protein count
Chain B 509–661(153 aa)
Chain D 509–661(153 aa)
Chain E 30–508(479 aa)
Chain G 30–508(479 aa)
Chain O 509–661(153 aa)
Chain P 30–508(479 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.50 Å
6OZ4 Crystal structure of broadly neutralizing antibody N49P6 Fab in complex with HIV-1 BG505 SOSIP.664 Env trimer ectodomain. Deposited 2019-05-15 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain B 509–661(153 aa)
Chain G 30–505(476 aa)
Mutation:I559P, T605C Mutation:T330N, A498C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 21 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;294 K;12% PEG 3350 0.1 M Tris-HCl pH 8.0
Resolution 4.05 Å R-free 0.315
6OZC BG505 SOSIP.664 with 2G12 Fab2 Deposited 2019-05-15 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain A 30–504(475 aa)
Chain B 509–661(153 aa)
Chain E 30–504(475 aa)
Chain F 30–504(475 aa)
Chain G 509–661(153 aa)
Chain I 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 21 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.79 Å
6PW6 The HIV-1 Envelope Glycoprotein Clone BG505 SOSIP.664 in Complex with Three Copies of the Bovine Broadly Neutralizing Antibody, NC-Cow1, Fragment Antigen Binding Domain Deposited 2019-07-22 Assembly 1 Other combination Heteromer;Protein × 9 PDB declaration: nonameric(9) Consistent with protein count
Chain A 30–505(476 aa)
Chain B 509–661(153 aa)
Chain C 30–505(476 aa)
Chain D 509–661(153 aa)
Chain E 30–505(476 aa)
Chain F 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 36 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.50 Å
6U0L Asymmetrically open conformational state (Class I) of HIV-1 Env trimer BG505 SOSIP.664 in complex with sCD4 and E51 Fab Deposited 2019-08-14 Assembly 1 Other combination Heteromer;Protein × 15 PDB declaration: pentadecameric(15) Consistent with protein count
Chain A 30–505(476 aa)
Chain B 30–505(476 aa)
Chain C 30–505(476 aa)
Chain X 509–661(153 aa)
Chain Y 509–661(153 aa)
Chain Z 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 21 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.30 Å
6U0N Asymmetrically open conformational state (Class II) of HIV-1 Env trimer BG505 SOSIP.664 in complex with sCD4 and E51 Fab Deposited 2019-08-14 Assembly 1 Other combination Heteromer;Protein × 15 PDB declaration: pentadecameric(15) Consistent with protein count
Chain A 32–505(474 aa)
Chain B 32–505(474 aa)
Chain C 32–505(474 aa)
Chain X 509–661(153 aa)
Chain Y 509–661(153 aa)
Chain Z 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 24 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.50 Å
6UDJ HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 Deposited 2019-09-19 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain C 509–661(153 aa) Fragment:UNP residues 509-661
Chain F 509–661(153 aa) Fragment:UNP residues 509-661
Chain G 32–505(474 aa) Fragment:UNP residues 32-505
Chain J 32–505(474 aa) Fragment:UNP residues 32-505
Chain M 509–661(153 aa) Fragment:UNP residues 509-661
Chain P 32–505(474 aa) Fragment:UNP residues 32-505
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 15 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE;0 blot force, 3.0 second blot time, 3 uL sample added to freshly glow discharged grids
Resolution 2.50 Å
6UTK Crystal structure of 438-B11 Fab in complex with an uncleaved prefusion optimized (UFO) soluble BG505 trimer and Fab 35O22 at 3.80 Angstrom Deposited 2019-10-29 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain G 30–503(474 aa) Fragment:UNP residues 30-503
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 24 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293.15 K;0.2 M sodium chloride, 36% v/v PEG400, 0.1 M sodium/potassium phosphate, pH 5.7
Resolution 3.80 Å R-free 0.317
6V0R BG505 SOSIP.664 Trimer Deposited 2019-11-19 Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain A 30–504(475 aa) Fragment:UNP residues 30-504
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain C 30–504(475 aa) Fragment:UNP residues 30-504
Chain D 30–504(475 aa) Fragment:UNP residues 30-504
Chain E 509–661(153 aa) Fragment:UNP residues 509-661
Chain F 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 33 ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.87 Å
6V6W Crystal structure of antibody 438-B11 DSS mutant (Cys98A-100aA) in complex with an uncleaved prefusion optimized (UFO) soluble BG505 trimer and Fab 35O22 Deposited 2019-12-06 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain G 30–503(474 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 36 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277.15 K;12% 1-propanol, 0.1M MES (pH=6.5), 20% polyethylene glycol monomethyl ether 5000, 25% glycerol
Resolution 6.50 Å R-free 0.355
6V6W Crystal structure of antibody 438-B11 DSS mutant (Cys98A-100aA) in complex with an uncleaved prefusion optimized (UFO) soluble BG505 trimer and Fab 35O22 Deposited 2019-12-06 Assembly 2 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain C 30–503(474 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 36 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277.15 K;12% 1-propanol, 0.1M MES (pH=6.5), 20% polyethylene glycol monomethyl ether 5000, 25% glycerol
Resolution 6.50 Å R-free 0.355
6V8X VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure Deposited 2019-12-12 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 32–502(471 aa) Fragment:UNP residues 32-502
Chain E 32–502(471 aa) Fragment:UNP residues 32-502
Chain I 32–502(471 aa) Fragment:UNP residues 32-502
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 15 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.00 Å
6V8Z VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure Deposited 2019-12-12 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain A 31–502(472 aa) Fragment:UNP residues 31-502
Chain G 31–502(472 aa) Fragment:UNP residues 31-502
Chain M 31–502(472 aa) Fragment:UNP residues 31-502
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 21 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.90 Å
6VI0 Cryo-EM structure of VRC01.23 in complex with HIV-1 Env BG505 DS.SOSIP Deposited 2020-01-10 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 30–508(479 aa)
Chain F 509–661(153 aa)
Chain G 30–508(479 aa)
Chain I 30–508(479 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 36 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.43 Å
6VKN BG505 SOSIP.v5.2.N241.N289 in complex with rhesus macaque Fab RM19R Deposited 2020-01-21 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–504(475 aa)
Chain B 509–661(153 aa)
Chain C 30–504(475 aa)
Chain D 30–504(475 aa)
Chain E 509–661(153 aa)
Chain F 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 39 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.70 Å
6VLR BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20E1 and PGT122 Fab Deposited 2020-01-24 Assembly 1 Other combination Heteromer;Protein × 14 PDB declaration: tetradecameric(14) Consistent with protein count
Chain A 30–504(475 aa)
Chain B 509–661(153 aa)
Chain G 30–504(475 aa)
Chain H 30–504(475 aa)
Chain I 509–661(153 aa)
Chain J 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 24 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.42 Å
6VN0 BG505 SOSIP.v4.1 in complex with rhesus macaque Fab RM20F Deposited 2020-01-29 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–504(475 aa)
Chain B 509–661(153 aa)
Chain C 30–504(475 aa)
Chain D 30–504(475 aa)
Chain E 509–661(153 aa)
Chain F 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 21 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.25 Å
6VO0 BG505 SOSIP.v5.2 in complex with rabbit Fab 43A2 Deposited 2020-01-29 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–504(475 aa)
Chain B 509–661(153 aa)
Chain C 30–504(475 aa)
Chain D 30–504(475 aa)
Chain E 509–661(153 aa)
Chain F 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 27 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.52 Å
6VO1 BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20J Deposited 2020-01-29 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–504(475 aa)
Chain B 509–661(153 aa)
Chain C 30–504(475 aa)
Chain D 30–504(475 aa)
Chain E 509–661(153 aa)
Chain F 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.88 Å
6W03 Crystal Structure of HIV-1 BG505 DS-SOSIP.3mut Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.3 Angstrom Deposited 2020-02-28 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain B 509–661(153 aa) Fragment:ectodomain
Chain G 30–504(475 aa)
Mutation:I559P, T605C Mutation:N137A, I201C, N302M, T320L, A329P, T332N, A433C, A501C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 X-RAY DIFFRACTION
X-ray crystallization conditions EVAPORATION;298 K;75 mM imidazole pH6.5, 150 mM LiSO4, 3.8% PEG MPD and 6.2% PEG 3,350
Resolution 2.40 Å R-free 0.273
6X96 Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 10A fragment antigen binding variable domain Deposited 2020-06-02 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–510(481 aa)
Chain B 509–661(153 aa)
Chain C 30–510(481 aa)
Chain D 509–661(153 aa)
Chain G 30–510(481 aa)
Chain I 509–661(153 aa)
Mutation:T332N, A501C, E509R, K510R, A512R, V513R Mutation:I559P, T605C Mutation:T332N, A501C, E509R, K510R, A512R, V513R Mutation:I559P, T605C Mutation:T332N, A501C, E509R, K510R, A512R, V513R Mutation:I559P, T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 33 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;Detergent (DDM) added shortly prior to freezing
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.40 Å
6X97 Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 11A fragment antigen binding variable domain Deposited 2020-06-02 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–510(481 aa)
Chain B 509–661(153 aa)
Chain C 30–510(481 aa)
Chain D 509–661(153 aa)
Chain G 30–510(481 aa)
Chain I 509–661(153 aa)
Mutation:T332N, A501C, E509R, K510R, A512R, V513R Mutation:I559P, T605C Mutation:T332N, A501C, E509R, K510R, A512R, V513R Mutation:I559P, T605C Mutation:T332N, A501C, E509R, K510R, A512R, V513R Mutation:I559P, T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 27 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;Detergent (DDM) added shortly prior to freezing
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.65 Å
6X98 Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 11B fragment antigen binding variable domain Deposited 2020-06-02 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–510(481 aa)
Chain B 509–661(153 aa)
Chain C 30–510(481 aa)
Chain D 509–661(153 aa)
Chain G 30–510(481 aa)
Chain I 509–661(153 aa)
Mutation:T332N, A501C, E509R, K510R, A512R, V513R Mutation:I559P, T605C Mutation:T332N, A501C, E509R, K510R, A512R, V513R Mutation:I559P, T605C Mutation:T332N, A501C, E509R, K510R, A512R, V513R Mutation:I559P, T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 36 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;Detergent (DDM) added shortly prior to freezing
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.38 Å
6X9R HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293F cells in complex with RM20A3 Fab Deposited 2020-06-03 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa)
Mutation:T332N,A501C Mutation:I559P,T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 51 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.6
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.10 Å
6X9R HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293F cells in complex with RM20A3 Fab Deposited 2020-06-03 Assembly 2 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa)
Mutation:T332N,A501C Mutation:I559P,T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 17 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.6
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.10 Å
6X9R HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293F cells in complex with RM20A3 Fab Deposited 2020-06-03 Assembly 3 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa)
Mutation:T332N,A501C Mutation:I559P,T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 17 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.6
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.10 Å
6X9S HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in stable CHO cells in complex with RM20A3 Fab Deposited 2020-06-03 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa)
Mutation:T332N,A501C Mutation:I559P,T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 51 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.6
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.10 Å
6X9S HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in stable CHO cells in complex with RM20A3 Fab Deposited 2020-06-03 Assembly 2 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa)
Mutation:T332N,A501C Mutation:I559P,T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 17 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.6
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.10 Å
6X9S HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in stable CHO cells in complex with RM20A3 Fab Deposited 2020-06-03 Assembly 3 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa)
Mutation:T332N,A501C Mutation:I559P,T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 17 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.6
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.10 Å
6X9T HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293S cells in complex with RM20A3 Fab Deposited 2020-06-03 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa)
Mutation:T332N,A501C Mutation:I559P,T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 51 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.6
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
6X9T HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293S cells in complex with RM20A3 Fab Deposited 2020-06-03 Assembly 2 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa)
Mutation:T332N,A501C Mutation:I559P,T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 17 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.6
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
6X9T HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293S cells in complex with RM20A3 Fab Deposited 2020-06-03 Assembly 3 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa)
Mutation:T332N,A501C Mutation:I559P,T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 17 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.6
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
6X9U HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and partially deglycosylated by endoglycosidase H, in complex with RM20A3 Fab Deposited 2020-06-03 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa)
Mutation:T332N,A501C Mutation:I559P,T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 51 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.6
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
6X9U HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and partially deglycosylated by endoglycosidase H, in complex with RM20A3 Fab Deposited 2020-06-03 Assembly 2 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa)
Mutation:T332N,A501C Mutation:I559P,T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 17 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.6
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
6X9U HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and partially deglycosylated by endoglycosidase H, in complex with RM20A3 Fab Deposited 2020-06-03 Assembly 3 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa)
Mutation:T332N,A501C Mutation:I559P,T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 17 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.6
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
6X9V HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and deglycosylated by endoglycosidase H, in complex with RM20A3 Fab Deposited 2020-06-03 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa)
Mutation:T332N,A501C Mutation:I559P,T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 51 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.6
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.50 Å
6X9V HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and deglycosylated by endoglycosidase H, in complex with RM20A3 Fab Deposited 2020-06-03 Assembly 2 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa)
Mutation:T332N,A501C Mutation:I559P,T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 17 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.6
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.50 Å
6X9V HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and deglycosylated by endoglycosidase H, in complex with RM20A3 Fab Deposited 2020-06-03 Assembly 3 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa)
Mutation:T332N,A501C Mutation:I559P,T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 17 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.6
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.50 Å
6XRT Cryo-EM structure of SHIV-elicited RHA1.V2.01 in complex with HIV-1 Env BG505 DS-SOSIP.664 Deposited 2020-07-13 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 509–661(153 aa)
Chain E 30–505(476 aa)
Chain F 30–505(476 aa)
Chain G 30–505(476 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 40 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.90 Å
7KDE BG505 SOSIP.664 in complex with the V3-targeting rhesus macaque antibody 1485 and human gp120-gp41 interface antibody 8ANC195 Deposited 2020-10-08 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 509–661(153 aa)
Chain E 32–505(474 aa)
Chain F 32–505(474 aa)
Chain G 32–505(474 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 34 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE;3s blot, blot force 0
Resolution 3.55 Å
7LG6 BG505 SOSIP.v5.2 in complex with VRC40.01 and RM19R Fabs Deposited 2021-01-19 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain A 30–504(475 aa)
Chain B 509–661(153 aa)
Chain E 30–504(475 aa)
Chain F 30–504(475 aa)
Chain G 509–661(153 aa)
Chain I 509–661(153 aa)
Mutation:E64K, A73C, A316W, T332N, A501C Mutation:I559P, A561C, T605C Mutation:E64K, A73C, A316W, T332N, A501C Mutation:E64K, A73C, A316W, T332N, A501C Mutation:I559P, A561C, T605C Mutation:I559P, A561C, T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.28 Å
7LL1 Cryo-EM structure of BG505 DS-SOSIP in complex with glycan276-dependent broadly neutralizing antibody VRC40.01 Fab Deposited 2021-02-03 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–502(473 aa)
Chain C 30–502(473 aa)
Chain G 30–502(473 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE;Blot for 2.5 S before plunging
Resolution 3.73 Å
7LL2 Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody VRC33.01 Fab Deposited 2021-02-03 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–502(473 aa)
Chain C 30–502(473 aa)
Chain E 30–502(473 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE;Blot for 2.5 S before plunging
Resolution 3.73 Å
7LO6 Structure of CD4 mimetic BNM-III-170 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab Deposited 2021-02-09 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 32–508(477 aa)
Chain B 509–661(153 aa)
Chain C 32–508(477 aa)
Chain D 509–661(153 aa)
Chain E 32–508(477 aa)
Chain F 509–661(153 aa)
Mutation:BG505 SOSIP.664 Mutation:BG505 SOSIP.664 Mutation:BG505 SOSIP.664 Mutation:BG505 SOSIP.664 Mutation:BG505 SOSIP.664 Mutation:BG505 SOSIP.664 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 27 5VG ~{N}'-[(1~{R},2~{R})-2-(carbamimidamidomethyl)-5-(methylaminomethyl)-2,3-dihydro-1~{H}-inden-1-yl]-~{N}-(4-chloranyl-3-fluoranyl-phenyl)ethanediamide × 3 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.90 Å
7LOK Structure of CD4 mimetic M48U1 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab Deposited 2021-02-10 Assembly 1 Other combination Heteromer;Protein × 13 PDB declaration: tridecameric(13) Consistent with protein count
Chain A 32–508(477 aa)
Chain B 509–661(153 aa)
Chain C 32–508(477 aa)
Chain D 509–661(153 aa)
Chain E 32–508(477 aa)
Chain F 509–661(153 aa)
Mutation:BG505 SOSIP.664 Mutation:BG505 SOSIP.664 Mutation:BG505 SOSIP.664 Mutation:BG505 SOSIP.664 Mutation:BG505 SOSIP.664 Mutation:BG505 SOSIP.664 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.90 Å
7LPN Cryo-EM structure of llama J3 VHH antibody in complex with HIV-1 Env BG505 DS-SOSIP.664 Deposited 2021-02-12 Assembly 1 Other combination Heteromer;Protein × 9 PDB declaration: nonameric(9) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 30–505(476 aa)
Chain E 509–661(153 aa)
Chain F 30–505(476 aa)
Chain G 30–505(476 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 33 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.61 Å
7MDT BG505 SOSIP.v5.2 in complex with the monoclonal antibody Rh4O9.8 (as Fab fragment) Deposited 2021-04-06 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 30–508(479 aa)
Chain B 509–661(153 aa)
Chain C 30–508(479 aa)
Chain D 509–661(153 aa)
Chain E 30–508(479 aa)
Chain F 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 31 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;TBS, 0.2um filtered
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.60 Å
7MDU BG505 SOSIP MD39 in complex with the monoclonal antibodies Rh.33104 mAb.1 and RM20A3 Deposited 2021-04-06 Assembly 1 Other combination Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain A 30–508(479 aa)
Chain B 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;TBS, 0.2um filtered
cryo-EM vitrification conditions Cryogen ETHANE;Blot force: 0 Wait time: 10s Blot time: 3-7s
Resolution 3.30 Å
7MXE Ab1245 Fab in complex with BG505 SOSIP.664 and 8ANC195 Fab Deposited 2021-05-19 Assembly 1 Other combination Heteromer;Protein × 14 PDB declaration: tetradecameric(14) Consistent with protein count
Chain C 509–661(153 aa)
Chain D 509–661(153 aa)
Chain F 509–661(153 aa)
Chain G 32–508(477 aa)
Chain J 32–508(477 aa)
Chain P 32–508(477 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 23 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE;0 blot force, 3 second blot time, 3 uL sample added
Resolution 3.70 Å
7RAI Cryo-EM structure of M4008_N1 Fab in complex with BG505 DS-SOSIP.664 Env trimer Deposited 2021-07-01 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–505(476 aa)
Chain B 509–661(153 aa)
Chain C 30–505(476 aa)
Chain D 509–661(153 aa)
Chain E 30–505(476 aa)
Chain F 509–661(153 aa)
Mutation:I200C, T330N, A430C, A498C Mutation:I556P, T602C Mutation:I200C, T330N, A430C, A498C Mutation:I556P, T602C Mutation:I200C, T330N, A430C, A498C Mutation:I556P, T602C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 21 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.24 Å
7SQ1 BG505.MD39TS Env trimer in complex with Fab from antibody C05 Deposited 2021-11-04 Assembly 1 Other combination Heteromer;Protein × 10 PDB declaration: decameric(10) Consistent with protein count
Chain B 509–661(153 aa)
Chain C 31–502(472 aa)
Chain D 509–661(153 aa)
Chain E 31–502(472 aa)
Chain F 509–661(153 aa)
Chain G 31–502(472 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 41 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.80 Å
7T9B ApexGT5 in complex with GT5-d42.16 and RM20A3 Fabs Deposited 2021-12-18 Assembly 1 Other combination Heteromer;Protein × 14 PDB declaration: tetradecameric(14) Consistent with protein count
Chain B 509–661(153 aa)
Chain D 509–661(153 aa)
Chain F 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 41 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.72 Å
7TFN Cryo-EM structure of CD4bs antibody Ab1303 in complex with HIV-1 Env trimer BG505 SOSIP.664 Deposited 2022-01-06 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain X 509–661(153 aa) Fragment:UNP residues 509-661
Chain Y 509–661(153 aa) Fragment:UNP residues 509-661
Chain Z 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8 MAN alpha-D-mannopyranose × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.00 Å
7TFO Cryo-EM structure of HIV-1 Env trimer BG505 SOSIP.664 in complex with CD4bs antibody Ab1573 Deposited 2022-01-06 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain X 509–661(153 aa) Fragment:UNP residues 509-661
Chain Y 509–661(153 aa) Fragment:UNP residues 509-661
Chain Z 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.10 Å
7TXD Cryo-EM structure of BG505 SOSIP HIV-1 Env trimer in complex with CD4 receptor (D1D2) and broadly neutralizing darpin bnD.9 Deposited 2022-02-08 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–505(476 aa)
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain C 30–505(476 aa)
Chain D 509–661(153 aa) Fragment:UNP residues 509-661
Chain E 30–505(476 aa)
Chain F 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 30 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.87 Å
7UCF Structure of the BG505 SOSIP.664 trimer in complex with neutralizing antibody Fab fragments 10-1074 and BG24 Deposited 2022-03-16 Assembly 1 Other combination Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain G 29–505(477 aa) Fragment:UNP residues 29-505
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 FUC alpha-L-fucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.5;295 K;0.1 M Bis-Tris pH 6.5, 20% PEG1500
Resolution 4.00 Å R-free 0.277
7UOJ The CryoEM structure of N49-P9.6-FR3 and PGT121 Fabs in complex with BG505 SOSIP.664 Deposited 2022-04-13 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain A 30–505(476 aa)
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain C 509–661(153 aa) Fragment:UNP residues 509-661
Chain G 30–505(476 aa)
Chain I 30–505(476 aa)
Chain J 509–661(153 aa) Fragment:UNP residues 509-661
Mutation:T330N,A498C Mutation:I556P,T602C Mutation:I556P,T602C Mutation:T330N,A498C Mutation:T330N,A498C Mutation:I556P,T602C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 15 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.2;Phosphate buffered saline
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.02 Å
8DP1 Cryo-EM structure of HIV-1 Env(BG505.T332N SOSIP) in complex with DH1030.1 Fab Deposited 2022-07-14 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain B 30–505(476 aa) Fragment:gp120
Chain H 509–661(153 aa) Fragment:UNP residues 509-661
Chain J 30–505(476 aa) Fragment:gp120
Chain Q 509–661(153 aa) Fragment:UNP residues 509-661
Chain S 509–661(153 aa) Fragment:UNP residues 509-661
Chain W 30–505(476 aa) Fragment:gp120
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 33 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.46 Å
8E1P Crystal structure of BG505 SOSIP.v4.1-GT1.2 trimer in complex with gl-PGV20 and PGT124 Fabs Deposited 2022-08-11 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain X 509–661(153 aa) Fragment:UNP residues 509-661
Chain Y 509–661(153 aa) Fragment:UNP residues 509-661
Chain Z 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 30 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277.15 K;0.2 M ammonium sulfate, 0.1 M Tris, pH 8.5, 12% w/v PEG8000
Resolution 3.82 Å R-free 0.301
8EUU Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01 FAB Deposited 2022-10-19 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–510(481 aa) Fragment:UNP residues 30-510
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain C 30–510(481 aa) Fragment:UNP residues 30-510
Chain D 509–661(153 aa) Fragment:UNP residues 509-661
Chain E 30–510(481 aa) Fragment:UNP residues 30-510
Chain F 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 15 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.70 Å
8EUV Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01-COMBO1 FAB Deposited 2022-10-19 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–510(481 aa) Fragment:UNP residues 30-510
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain C 30–510(481 aa) Fragment:UNP residues 30-510
Chain D 509–661(153 aa) Fragment:UNP residues 509-661
Chain E 30–510(481 aa) Fragment:UNP residues 30-510
Chain F 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 15 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.60 Å
8EUW Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01-MM28 FAB Deposited 2022-10-19 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 30–510(481 aa) Fragment:UNP residues 30-510
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain C 30–510(481 aa) Fragment:UNP residues 30-510
Chain D 509–661(153 aa) Fragment:UNP residues 509-661
Chain E 30–510(481 aa) Fragment:UNP residues 30-510
Chain F 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 21 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.70 Å
8FIS Structure of Bispecific CAP256V2LS-J3 Fab in complex with BG505 DS-SOSIP.664 Deposited 2022-12-16 Assembly 1 Other combination Heteromer;Protein × 10 PDB declaration: decameric(10) Consistent with protein count
Chain A 509–661(153 aa) Fragment:UNP residues 509-661
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain C 30–510(481 aa) Fragment:UNP residues 30-510
Chain E 509–661(153 aa) Fragment:UNP residues 509-661
Chain F 30–510(481 aa) Fragment:UNP residues 30-510
Chain G 30–510(481 aa) Fragment:UNP residues 30-510
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 25 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;PBS
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.18 Å
8FK5 Cryo-EM Structure of PG9RSH DU011 Fab in complex with BG505 DS-SOSIP.664 Deposited 2022-12-20 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 509–661(153 aa) Fragment:UNP residues 509-661
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain C 30–510(481 aa) Fragment:UNP residues 30-510
Chain F 509–661(153 aa) Fragment:UNP residues 509-661
Chain G 30–510(481 aa) Fragment:UNP residues 30-510
Chain I 30–510(481 aa) Fragment:UNP residues 30-510
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 38 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;PBS
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.40 Å
8FL1 Cryo-EM Structure of PG9RSH DU025 Fab in complex with BG505 DS-SOSIP.664 Deposited 2022-12-21 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 509–661(153 aa) Fragment:UNP residues 509-661
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain C 30–510(481 aa) Fragment:UNP residues 30-510
Chain F 509–661(153 aa) Fragment:UNP residues 509-661
Chain G 30–510(481 aa) Fragment:UNP residues 30-510
Chain I 30–510(481 aa) Fragment:UNP residues 30-510
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 40 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;PBS
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.75 Å
8FLW Cryo-EM Structure of PGT145 DU303 Fab in complex with BG505 DS-SOSIP.664 Deposited 2022-12-22 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 509–661(153 aa) Fragment:UNP residues 509-661
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain C 30–510(481 aa) Fragment:UNP residues 30-510
Chain F 509–661(153 aa) Fragment:UNP residues 509-661
Chain G 30–510(481 aa) Fragment:UNP residues 30-510
Chain I 30–510(481 aa) Fragment:UNP residues 30-510
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 35 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;PBS
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.58 Å
8FR6 Antibody vFP53.02 in complex with HIV-1 envelope trimer BG505 DS-SOSIP Deposited 2023-01-06 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain C 30–502(473 aa)
Chain G 30–502(473 aa)
Chain I 30–502(473 aa)
Mutation:BG505 DS-SOSIP construct Mutation:BG505 DS-SOSIP construct Mutation:BG505 DS-SOSIP construct NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 21 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.2
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.50 Å
8FYJ Structure of HIV-1 BG505 SOSIP-HT2 in complex with two CD4 molecules (class I) Deposited 2023-01-26 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain D 509–661(153 aa)
Chain E 509–661(153 aa)
Chain F 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.00 Å
8G4M Vaccine-elicited human antibody 2C06 in complex with HIV-1 envelope trimer BG505 DS-SOSIP Deposited 2023-02-10 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain C 30–502(473 aa)
Chain G 30–502(473 aa)
Chain I 30–502(473 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;PBS + 0.005%(w/v) DDM
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.95 Å
8G4T Vaccine-elicited human antibody 2C09 in complex with HIV-1 envelope trimer BG505 DS-SOSIP Deposited 2023-02-10 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain C 30–502(473 aa)
Chain G 30–502(473 aa)
Chain I 30–502(473 aa)
Mutation:BG505 DS-SOSIP mutations Mutation:BG505 DS-SOSIP mutations Mutation:BG505 DS-SOSIP mutations NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 15 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;PBS + 0.1mM DDM
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.81 Å
8G85 vFP52.02 Fab in complex with BG505 DS-SOSIP Env trimer Deposited 2023-02-17 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain D 30–510(481 aa) Fragment:UNP residues 30-510
Chain E 509–661(153 aa) Fragment:UNP residues 509-661
Chain G 30–510(481 aa) Fragment:UNP residues 30-510
Chain J 30–510(481 aa) Fragment:UNP residues 30-510
Chain K 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 35 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;PBS
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.99 Å
8G9W Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 1) Deposited 2023-02-22 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain D 509–661(153 aa) Fragment:UNP residues 509-661
Chain E 30–510(481 aa) Fragment:UNP residues 30-510
Chain G 30–510(481 aa) Fragment:UNP residues 30-510
Chain O 509–661(153 aa) Fragment:UNP residues 509-661
Chain P 30–510(481 aa) Fragment:UNP residues 30-510
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 15 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.66 Å
8G9X Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 2) Deposited 2023-02-22 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain D 509–661(153 aa) Fragment:UNP residues 509-661
Chain E 30–510(481 aa) Fragment:UNP residues 30-510
Chain G 30–510(481 aa) Fragment:UNP residues 30-510
Chain O 509–661(153 aa) Fragment:UNP residues 509-661
Chain P 30–510(481 aa) Fragment:UNP residues 30-510
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 15 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.46 Å
8G9Y Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 3) Deposited 2023-02-22 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain D 509–661(153 aa) Fragment:UNP residues 509-661
Chain E 30–510(481 aa) Fragment:UNP residues 30-510
Chain G 30–510(481 aa) Fragment:UNP residues 30-510
Chain O 509–661(153 aa) Fragment:UNP residues 509-661
Chain P 30–510(481 aa) Fragment:UNP residues 30-510
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 15 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.28 Å
8GAS vFP48.02 Fab in complex with BG505 DS-SOSIP Env trimer Deposited 2023-02-23 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain D 30–505(476 aa) Fragment:UNP residues 30-505
Chain E 509–661(153 aa) Fragment:UNP residues 509-661
Chain G 30–505(476 aa) Fragment:UNP residues 30-505
Chain J 30–505(476 aa) Fragment:UNP residues 30-505
Chain K 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 36 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;PBS
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.04 Å
8SW3 BG505 GT1.1 SOSIP in complex with NHP Fabs 12C11 and RM20A3 Deposited 2023-05-17 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain E 509–661(153 aa) Fragment:UNP residues 509-661
Chain F 509–661(153 aa) Fragment:UNP residues 509-661
Mutation:I559P, T605C Mutation:I559P, T605C Mutation:I559P, T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 42 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;Detergent added shortly before freezing
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.80 Å
8SW4 BG505 GT1.1 SOSIP in complex with NHP Fabs 21N13, 21M20 and RM20A3 Deposited 2023-05-17 Assembly 1 Other combination Heteromer;Protein × 20 PDB declaration: eicosameric(20) Consistent with protein count
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain G 509–661(153 aa) Fragment:UNP residues 509-661
Chain I 509–661(153 aa) Fragment:UNP residues 509-661
Mutation:I559P, T605C Mutation:I559P, T605C Mutation:I559P, T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 33 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;Detergent added shortly before freezing
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.85 Å
8TGO Crystal structure of the BG505 triple tandem trimer gp140 HIV-1 Env in complex with PGT124 and 35O22 Deposited 2023-07-12 Assembly 1 Other combination Heteromer;Protein × 15 PDB declaration: pentadecameric(15) Consistent with protein count
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain G 30–504(475 aa) Fragment:UNP residues 30-504
Chain H 509–661(153 aa) Fragment:UNP residues 509-661
Chain R 30–504(475 aa) Fragment:UNP residues 30-504
Chain a 509–661(153 aa) Fragment:UNP residues 509-661
Chain e 30–504(475 aa) Fragment:UNP residues 30-504
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 31 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277.15 K;0.1 M sodium acetate, 0.2 M zinc acetate, 11.5 % w/v PEG3000, pH 4.83
Resolution 5.75 Å R-free 0.292
8TJR CRYO-EM STRUCTURE OF HIV-1 BG505DS-SOSIP.664 ENV TRIMER BOUND TO HERH-a.01 FAB Deposited 2023-07-24 Assembly 1 Other combination Heteromer;Protein × 10 PDB declaration: decameric(10) Consistent with protein count
Chain A 30–504(475 aa)
Chain B 30–504(475 aa)
Chain C 30–504(475 aa)
Chain D 509–661(153 aa)
Chain E 509–661(153 aa)
Chain F 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 48 ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.29 Å
8TJS CRYO-EM STRUCTURE OF HIV-1 BG505DS-SOSIP.664 ENV TRIMER BOUND TO GPZ6-a.01 FAB Deposited 2023-07-24 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: 12-meric(12) Consistent with protein count
Chain B 509–661(153 aa)
Chain G 30–502(473 aa)
Chain H 509–661(153 aa)
Chain I 509–661(153 aa)
Chain N 30–502(473 aa)
Chain O 30–502(473 aa)
Mutation:I556P, T602C Mutation:I556P, T602C Mutation:I556P, T602C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 48 ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.31 Å
8TNG Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with broadly neutralizing llama nanobody R27 targeting the CD4-binding site Deposited 2023-08-01 Assembly 1 Other combination Heteromer;Protein × 9 PDB declaration: nonameric(9) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain C 30–505(476 aa) Fragment:UNP residues 30-505
Chain D 509–661(153 aa) Fragment:UNP residues 509-661
Chain E 30–505(476 aa) Fragment:UNP residues 30-505
Chain F 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 27 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.58 Å
8TNH Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with broadly neutralizing llama nanobody G36 targeting the CD4-binding site Deposited 2023-08-01 Assembly 1 Other combination Heteromer;Protein × 9 PDB declaration: nonameric(9) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain C 30–505(476 aa) Fragment:UNP residues 30-505
Chain D 509–661(153 aa) Fragment:UNP residues 509-661
Chain E 30–505(476 aa) Fragment:UNP residues 30-505
Chain F 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 27 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.32 Å
8TNI Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with broadly neutralizing bi-specific antibody CAP256L-R27 targeting the CD4-binding site and the V2-apex Deposited 2023-08-01 Assembly 1 Other combination Heteromer;Protein × 10 PDB declaration: decameric(10) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain C 30–505(476 aa) Fragment:UNP residues 30-505
Chain D 509–661(153 aa) Fragment:UNP residues 509-661
Chain E 30–505(476 aa) Fragment:UNP residues 30-505
Chain F 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 32 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.61 Å
8TOP Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with antibody GPZ6-b.01 targeting the fusion peptide Deposited 2023-08-03 Assembly 1 Other combination Heteromer;Protein × 24 PDB declaration: 24-meric(24) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 509–661(153 aa) Fragment:UNP residues 509-661
Chain C 30–505(476 aa) Fragment:UNP residues 30-505
Chain D 509–661(153 aa) Fragment:UNP residues 509-661
Chain E 30–505(476 aa) Fragment:UNP residues 30-505
Chain F 509–661(153 aa) Fragment:UNP residues 509-661
Chain O 30–505(476 aa) Fragment:UNP residues 30-505
Chain P 509–661(153 aa) Fragment:UNP residues 509-661
Chain Q 30–505(476 aa) Fragment:UNP residues 30-505
Chain R 509–661(153 aa) Fragment:UNP residues 509-661
Chain S 30–505(476 aa) Fragment:UNP residues 30-505
Chain T 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 82 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 1.8 mM KH2PO4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.52 Å
8TOX Cryo-EM structure of BG505 Env mutant A517E in complex with antibody ACS202 Fab Deposited 2023-08-04 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 30–504(475 aa)
Chain F 509–661(153 aa)
Chain G 30–504(475 aa)
Chain I 30–504(475 aa)
Mutation:A517E, M535N, N543Q, T569G, I573F, R588E, D589V, S636G, N651F, K655I Mutation:A517E, M535N, N543Q, T569G, I573F, R588E, D589V, S636G, N651F, K655I Mutation:A517E, M535N, N543Q, T569G, I573F, R588E, D589V, S636G, N651F, K655I NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;PBS with 0.1 mM DTT
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.30 Å
8TQ1 HIV-1 BG505 Env SOSIP in complex with bovine Fab Bess4 and non-human primate Fab RM20A3 Deposited 2023-08-06 Assembly 1 Other combination Heteromer;Protein × 13 PDB declaration: 13-meric(13) Consistent with protein count
Chain A 30–505(476 aa)
Chain E 30–505(476 aa)
Chain J 30–505(476 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 45 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.30 Å
8TTW Cryo-EM structure of BG505 SOSIP.664 HIV-1 Env trimer in complex with temsavir, 8ANC195, and 10-1074 Deposited 2023-08-15 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain A 30–510(481 aa)
Chain E 30–510(481 aa)
Chain I 30–510(481 aa)
Mutation:A501C T332N E509R K510R A512R V513R Mutation:A501C T332N E509R K510R A512R V513R Mutation:A501C T332N E509R K510R A512R V513R NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 21 83J 1-[4-(benzenecarbonyl)piperazin-1-yl]-2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]ethane-1,2-dione × 3 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.2
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.96 Å
8ULR Cryo-EM structure of the BG505 SOSIPv2 in complex with bNAb 05_B08 Fabs Deposited 2023-10-16 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 32–501(470 aa)
Chain C 32–501(470 aa)
Chain E 32–501(470 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 14 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE;3s blot, 0 blot force
Resolution 3.30 Å
8ULS Cryo-EM structure of the BG505 SOSIPv2 in complex with bNAb 01_D03 Fabs Deposited 2023-10-16 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: 12-meric(12) Consistent with protein count
Chain A 32–501(470 aa)
Chain C 32–501(470 aa)
Chain E 32–501(470 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 15 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE;3s blot, 0 blot force
Resolution 3.20 Å
8ULT Cryo-EM structure of the BG505 SOSIPv2 in complex with bNAb 04_A06 Fabs Deposited 2023-10-16 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: 12-meric(12) Consistent with protein count
Chain A 32–501(470 aa)
Chain C 32–501(470 aa)
Chain E 32–501(470 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 29 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE;3s blot, 0 blot force
Resolution 3.80 Å
8ULU Cryo-EM structure of the BG505 SOSIPv2 in complex with bNAb 04_A06 and PGDM1400 Fabs Deposited 2023-10-16 Assembly 1 Other combination Heteromer;Protein × 14 PDB declaration: 14-meric(14) Consistent with protein count
Chain A 32–501(470 aa)
Chain C 32–501(470 aa)
Chain E 32–501(470 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE;3s blot, 0 blot force
Resolution 3.80 Å
8VFV HIV Env BG505_MD39_B16 SOSIP boosting trimer in complex with B16_d77.5 mouse Fab and RM20A3 Fab Deposited 2023-12-22 Assembly 1 Other combination Heteromer;Protein × 14 PDB declaration: tetradecameric(14) Consistent with protein count
Chain A 30–510(481 aa)
Chain B 509–661(153 aa)
Chain E 30–510(481 aa)
Chain F 509–661(153 aa)
Chain J 30–510(481 aa)
Chain K 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 36 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.30 Å
9AUG Cryo-EM structure of CH848.d949.10.17.GS-DH270.UCA3.G57R Deposited 2024-02-29 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: 12-meric(12) Consistent with protein count
Chain A 30–495(466 aa) Fragment:d949.GS-gp120
Chain B 30–495(466 aa) Fragment:d949.GS-gp120
Chain C 30–495(466 aa) Fragment:d949.GS-gp120
Chain D 509–661(153 aa) Fragment:UNP residues 509-661
Chain E 509–661(153 aa) Fragment:UNP residues 509-661
Chain F 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 27 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.80 Å
9AUH Cryo-EM structure of CH848.d949.10.17.GS-DH270.UCA3 Deposited 2024-02-29 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: 12-meric(12) Consistent with protein count
Chain A 30–495(466 aa) Fragment:d949.GS-gp120
Chain B 30–495(466 aa) Fragment:d949.GS-gp120
Chain C 30–495(466 aa) Fragment:d949.GS-gp120
Chain D 509–661(153 aa) Fragment:UNP residues 509-661
Chain E 509–661(153 aa) Fragment:UNP residues 509-661
Chain F 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 30 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.60 Å
9AUI Cryo-EM structure of CH848.d949.10.17.GS-DH270.UCA4 Deposited 2024-02-29 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: 12-meric(12) Consistent with protein count
Chain A 30–495(466 aa) Fragment:d949.GS-gp120
Chain B 30–495(466 aa) Fragment:d949.GS-gp120
Chain C 30–495(466 aa) Fragment:d949.GS-gp120
Chain D 509–661(153 aa) Fragment:UNP residues 509-661
Chain E 509–661(153 aa) Fragment:UNP residues 509-661
Chain F 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 27 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.80 Å
9AXD HIV BG505.v5.2 (N289/N241) SOSIP Env in Complex with gp120-Interface pAb from Rh.33203 Deposited 2024-03-06 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 30–508(479 aa)
Chain B 507–661(155 aa)
Chain C 30–508(479 aa)
Chain D 507–661(155 aa)
Chain E 30–508(479 aa)
Chain F 507–661(155 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 40 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.80 Å
9AY6 HIV BG505.v5.2 (N289/N241) SOSIP Env in Complex with V5 pAb from Rh.33203 Deposited 2024-03-07 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 30–508(479 aa)
Chain B 507–661(155 aa)
Chain C 30–508(479 aa)
Chain D 507–661(155 aa)
Chain E 30–508(479 aa)
Chain F 507–661(155 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 31 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.00 Å
9AYS HIV BG505.v5.2 (N289/N241) SOSIP Env in Complex with V5, gp120-Interface, and Anti-Immune Complex pAbs from Rh.33203 Deposited 2024-03-08 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: 12-meric(12) Consistent with protein count
Chain A 30–508(479 aa)
Chain B 507–661(155 aa)
Chain C 30–508(479 aa)
Chain D 507–661(155 aa)
Chain E 30–508(479 aa)
Chain F 507–661(155 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 43 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.60 Å
9AYV HIV CH505/BG505 SOSIP.v8.1 Env in Complex with V1/V3 Epitope and Anti-Immune Complex pAbs from Rabbit 2474 Deposited 2024-03-08 Assembly 1 Other combination Heteromer;Protein × 10 PDB declaration: decameric(10) Consistent with protein count
Chain B 507–661(155 aa)
Chain D 507–661(155 aa)
Chain F 507–661(155 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 38 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.40 Å
9B8B RM038 Fab in complex with Apex-GT 6.2 trimer and RM20A3 Fab Deposited 2024-03-29 Assembly 1 Other combination Heteromer;Protein × 14 PDB declaration: tetradecameric(14) Consistent with protein count
Chain A 30–505(476 aa)
Chain B 509–661(153 aa)
Chain C 30–505(476 aa)
Chain D 30–505(476 aa)
Chain E 509–661(153 aa)
Chain F 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 49 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
9B8C RM018 Fab in complex with Apex GT 6.2 trimer and RM20A3 Fab Deposited 2024-03-29 Assembly 1 Other combination Heteromer;Protein × 14 PDB declaration: tetradecameric(14) Consistent with protein count
Chain A 30–504(475 aa)
Chain B 509–661(153 aa)
Chain C 30–504(475 aa)
Chain D 30–504(475 aa)
Chain E 509–661(153 aa)
Chain F 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 48 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.30 Å
9BNK Cryo-EM structure of rhesus antibody V031-a.01 in complex with HIV-1 Env BG505 DS-SOSIP Deposited 2024-05-02 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 515–661(147 aa)
Chain B 515–661(147 aa)
Chain C 515–661(147 aa)
Chain E 31–503(473 aa)
Chain F 31–503(473 aa)
Chain G 31–503(473 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 39 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.10 Å
9BNM Cryo-EM structure of rhesus antibody 44715-a.01 in complex with HIV-1 Env BG505 DS-SOSIP Deposited 2024-05-02 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 30–505(476 aa)
Chain B 30–505(476 aa)
Chain C 30–505(476 aa)
Chain X 510–661(152 aa)
Chain Y 510–661(152 aa)
Chain Z 510–661(152 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 19 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.97 Å
9BNP Cryo-EM structure of rhesus antibody V033-a.01 in complex with HIV-1 Env BG505 DS-SOSIP Deposited 2024-05-02 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 32–502(471 aa)
Chain B 517–661(145 aa)
Chain E 32–502(471 aa)
Chain F 517–661(145 aa)
Chain I 32–502(471 aa)
Chain J 517–661(145 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.17 Å
9BTL Cryo-EM structure of rhesus antibody 41328-a.01 in complex with HIV-1 Env BG505 DS-SOSIP Deposited 2024-05-15 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 30–505(476 aa)
Chain B 510–661(152 aa)
Chain E 30–505(476 aa)
Chain F 510–661(152 aa)
Chain I 30–505(476 aa)
Chain J 510–661(152 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 24 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.96 Å
9CF5 STRUCTURE OF CD4 MIMETIC CJF-III-288 IN COMPLEX WITH BG505 SOSIP.664 HIV-1ENV TRIMER AND 17B FAB Deposited 2024-06-27 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 32–508(477 aa)
Chain B 509–661(153 aa) Fragment:residues 512-664 (509-661 Uniprot numbering)
Chain C 32–508(477 aa)
Chain D 509–661(153 aa) Fragment:residues 512-664 (509-661 Uniprot numbering)
Chain E 32–508(477 aa)
Chain F 509–661(153 aa) Fragment:residues 512-664 (509-661 Uniprot numbering)
Mutation:T332N, A501C, E509R, K510R, insertion of RR after residue 511 Mutation:I559P, T605C Mutation:T332N, A501C, E509R, K510R, insertion of RR after residue 511 Mutation:I559P, T605C Mutation:T332N, A501C, E509R, K510R, insertion of RR after residue 511 Mutation:I559P, T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 26 Y26 propyl (2R,3S)-2-(carbamimidamidomethyl)-3-[2-(4-chloro-3-fluoroanilino)(oxo)acetamido]-6-[(methylamino)methyl]-2,3-dihydro-1H-indole-1-carboxylate × 3 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.2
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.50 Å
9D1W Cryo-EM structure of PGDM1400 Fab bound to HIV-1 BG505 DS-SOSIP.664 Env trimer Deposited 2024-08-08 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 30–505(476 aa) Fragment:UNP residues 30-505
Chain C 30–505(476 aa) Fragment:UNP residues 30-505
Chain a 509–661(153 aa) Fragment:UNP residues 509-661
Chain b 509–661(153 aa) Fragment:UNP residues 509-661
Chain c 509–661(153 aa) Fragment:UNP residues 509-661
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 33 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5;PBS
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.44 Å
9D3D Cryo-EM structure of PGT145 R100aS Fab bound to HIV-1 BG505 DS-SOSIP.664 Env trimer Deposited 2024-08-09 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain B 30–505(476 aa) Fragment:UNP residues 30-505
Chain C 30–505(476 aa) Fragment:UNP residues 30-505
Chain a 509–661(153 aa) Fragment:residues 512-664
Chain b 509–661(153 aa) Fragment:residues 512-664
Chain c 509–661(153 aa) Fragment:residues 512-664
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 24 PO4 PHOSPHATE ION × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;PBS
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.41 Å
9D8Y Cryo-EM structure of HIV-1 BG505 SOSIP.664 Env bound to 3-sCD4, 3-VRC34.01 Fab with one gp120 rotated, Population 4 Deposited 2024-08-20 Assembly 1 Other combination Heteromer;Protein × 15 PDB declaration: pentadecameric(15) Consistent with protein count
Chain D 509–661(153 aa) Fragment:UNP residues 509-611
Chain E 509–661(153 aa) Fragment:UNP residues 509-611
Chain F 509–661(153 aa) Fragment:UNP residues 509-611
Mutation:I559P,T605C Mutation:I559P,T605C Mutation:I559P,T605C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.06 Å
9DMB Rhesus RHA10.01 Fab in complex with HIV-1 Env BG505 DS-SOSIP trimer Deposited 2024-09-12 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: 12-meric(12) Consistent with protein count
Chain F 30–509(480 aa)
Chain K 30–509(480 aa)
Chain L 30–509(480 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 27 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;PBS
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.27 Å
9MI0 61-12A01 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab Deposited 2024-12-12 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain B 509–661(153 aa) Fragment:UNP residues 509-611
Chain D 509–661(153 aa) Fragment:UNP residues 509-611
Chain F 509–661(153 aa) Fragment:UNP residues 509-611
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 24 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.80 Å
9MIA 206-3G08 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab Deposited 2024-12-12 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: octadecameric(18) Consistent with protein count
Chain B 509–661(153 aa) Fragment:UNP residues 509-611
Chain D 509–661(153 aa) Fragment:UNP residues 509-611
Chain F 509–661(153 aa) Fragment:UNP residues 509-611
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 42 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.80 Å
9MIB 206-9C09 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab Deposited 2024-12-12 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: 18-meric(18) Consistent with protein count
Chain B 509–661(153 aa) Fragment:UNP residues 509-611
Chain D 509–661(153 aa) Fragment:UNP residues 509-611
Chain F 509–661(153 aa) Fragment:UNP residues 509-611
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 15 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.80 Å
9MIH 273-4D01 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab Deposited 2024-12-12 Assembly 1 Other combination Heteromer;Protein × 14 PDB declaration: 14-meric(14) Consistent with protein count
Chain A 30–505(476 aa)
Chain B 509–661(153 aa)
Chain C 30–505(476 aa)
Chain D 509–661(153 aa)
Chain E 30–505(476 aa)
Chain F 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 44 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.90 Å
9MII 253-7A03 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab Deposited 2024-12-12 Assembly 1 Other combination Heteromer;Protein × 14 PDB declaration: 14-meric(14) Consistent with protein count
Chain A 30–505(476 aa)
Chain B 509–661(153 aa)
Chain C 30–505(476 aa)
Chain D 509–661(153 aa)
Chain E 30–505(476 aa)
Chain F 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 44 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.30 Å
9MQG RM017 Fab in complex with Apex-GT6.2 trimer and RM20A3 Fab Deposited 2025-01-03 Assembly 1 Other combination Heteromer;Protein × 14 PDB declaration: tetradecameric(14) Consistent with protein count
Chain B 509–661(153 aa)
Chain E 509–661(153 aa)
Chain F 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 39 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.30 Å
9O2Q BG505-DS SOSIP in complex with 007 bNAb Fabs - Class 0 (unbound) Deposited 2025-04-04 Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain A 32–507(476 aa)
Chain B 508–661(154 aa)
Chain C 32–507(476 aa)
Chain D 508–661(154 aa)
Chain E 32–507(476 aa)
Chain F 508–661(154 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 21 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE;3s blot, 0 blot force
Resolution 2.90 Å
9O2R BG505-DS SOSIP in complex with 007 bNAb Fabs - Class 1 (1 Fab bound) Deposited 2025-04-04 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 32–507(476 aa)
Chain B 508–661(154 aa)
Chain C 32–507(476 aa)
Chain D 508–661(154 aa)
Chain E 32–507(476 aa)
Chain F 508–661(154 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 22 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE;3s blot, 0 blot force
Resolution 3.00 Å
9O2S BG505-DS SOSIP in complex with 007 bNAb Fabs - Class 2 (2 Fabs bound) Deposited 2025-04-04 Assembly 1 Other combination Heteromer;Protein × 10 PDB declaration: decameric(10) Consistent with protein count
Chain A 32–507(476 aa)
Chain B 508–661(154 aa)
Chain C 32–507(476 aa)
Chain D 508–661(154 aa)
Chain E 32–507(476 aa)
Chain F 508–661(154 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 23 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE;3s blot, 0 blot force
Resolution 3.20 Å
9O2T BG505-DS SOSIP in complex with 007 bNAb Fabs - Class 3 (3 Fabs bound) Deposited 2025-04-04 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 32–507(476 aa)
Chain B 508–661(154 aa)
Chain C 32–507(476 aa)
Chain D 508–661(154 aa)
Chain E 32–507(476 aa)
Chain F 508–661(154 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 24 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE;3s blot, 0 blot force
Resolution 3.40 Å
9O2U BG505 SOSIP in complex with 007 bNAb IgG1 - trimer-dimer class Deposited 2025-04-04 Assembly 1 Other combination Heteromer;Protein × 24 PDB declaration: 24-meric(24) Consistent with protein count
Chain A 32–507(476 aa)
Chain B 508–661(154 aa)
Chain C 32–507(476 aa)
Chain D 508–661(154 aa)
Chain E 32–507(476 aa)
Chain F 508–661(154 aa)
Chain O 32–507(476 aa)
Chain P 508–661(154 aa)
Chain Q 32–507(476 aa)
Chain R 508–661(154 aa)
Chain S 32–507(476 aa)
Chain T 508–661(154 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 48 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.20 Å
9O8M Ab1983 in complex with HIV-1 Env variant WIN332 Deposited 2025-04-16 Assembly 1 Other combination Heteromer;Protein × 10 PDB declaration: decameric(10) Consistent with protein count
Chain E 32–510(479 aa)
Chain F 509–661(153 aa)
Chain I 32–510(479 aa)
Chain J 509–661(153 aa)
Chain K 32–510(479 aa)
Chain L 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 22 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.6
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.79 Å
9OED Ab1999 in complex with HIV-1 Env RC1 Deposited 2025-04-28 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain D 509–661(153 aa)
Chain F 509–661(153 aa)
Chain J 509–661(153 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 23 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.6;1X PBS
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.94 Å
9OGM BG505 MD39.3 Env gp151 MPER nanodisc in complex with 10E8, BG18 and VRC01 Fabs (1x 10E8 Fab) Deposited 2025-05-01 Assembly 1 Insufficient information Heteromer;Protein × 17 PDB declaration: 17-meric(17) Consistent with protein count
Chain A 30–504(475 aa)
Chain B 30–504(475 aa)
Chain C 30–504(475 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 30 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.50 Å
9OGT HIV-1 Env BG505 SOSIP.664-His in complex with PGT122 and 3BNC117 Fabs Deposited 2025-05-01 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: 18-meric(18) Consistent with protein count
Chain A 30–505(476 aa)
Chain C 30–505(476 aa)
Chain E 30–505(476 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 30 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.00 Å
9OGU HIV-1 Env BG505 SOSIP.664-dPG-His in complex with PGT122 and 3BNC117 Fabs Deposited 2025-05-01 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: 18-meric(18) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain C 30–505(476 aa) Fragment:UNP residues 30-505
Chain E 30–505(476 aa) Fragment:UNP residues 30-505
Mutation:T332N, A501C Mutation:T332N, A501C Mutation:T332N, A501C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 28 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
9P6E N49P7-FR Fab in complex with BG505 MD39 SOSIP and RM20A3 Fab Deposited 2025-06-18 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: 18-meric(18) Consistent with protein count
Chain B 509–661(153 aa)
Chain D 509–661(153 aa)
Chain F 509–661(153 aa)
Mutation:F516S, I556P, S558P, L565D, V567H, R582H, T602C Mutation:F516S, I556P, S558P, L565D, V567H, R582H, T602C Mutation:F516S, I556P, S558P, L565D, V567H, R582H, T602C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 33 ELECTRON MICROSCOPY
cryo-EM buffer pH 5.9
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.70 Å
9P6G eN49P7-FRv1-23 Fab in complex with BG505 MD39 SOSIP and RM20A3 Fab Deposited 2025-06-19 Assembly 1 Other combination Heteromer;Protein × 18 PDB declaration: 18-meric(18) Consistent with protein count
Chain B 509–661(153 aa)
Chain D 509–661(153 aa)
Chain F 509–661(153 aa)
Mutation:F516S, I556P, S558P, L565D, V567H, R582H, T602C Mutation:F516S, I556P, S558P, L565D, V567H, R582H, T602C Mutation:F516S, I556P, S558P, L565D, V567H, R582H, T602C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 36 ELECTRON MICROSCOPY
cryo-EM buffer pH 5.9
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.70 Å
9PNI Cryo-EM structure of J601-1B2 Fab in complex with HIV-1 BG505 DS-SOSIP Env trimer Deposited 2025-07-21 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: 12-meric(12) Consistent with protein count
Chain C 30–502(473 aa)
Chain G 30–502(473 aa)
Chain I 30–502(473 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 19 MAN alpha-D-mannopyranose × 2 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;PBS buffer supplemented with 0.1 mM DDM
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.83 Å
9PNN Cryo-EM structure of J601-A6 Fab in complex with HIV-1 BG505 DS-SOSIP Env trimer Deposited 2025-07-21 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: 12-meric(12) Consistent with protein count
Chain C 30–502(473 aa)
Chain G 30–502(473 aa)
Chain I 30–502(473 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 15 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4;PBS + 0.005% (w/v) DDM
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.50 Å
9Q0W Cryo-EM Structure of HIV-1 BG505DS-SOSIP.664 Env Trimer Bound to DFPH-a.01_10R59P_LC Fab Deposited 2025-08-13 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: 12-meric(12) Consistent with protein count
Chain A 30–505(476 aa) Fragment:UNP residues 30-505
Chain C 30–505(476 aa) Fragment:UNP residues 30-505
Chain E 30–505(476 aa) Fragment:UNP residues 30-505
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.00 Å
9YHO AJ09-21 Fab in complex with HIV-1 Env 5MUT-3fill SOSIP Deposited 2025-09-30 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 509–661(153 aa)
Chain E 32–510(479 aa)
Chain F 32–510(479 aa)
Chain G 32–510(479 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 42 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;150 mM NaCl, 20 mM Tris-HCl, pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.20 Å
9YHQ AJ09-83 Fab in complex with HIV-1 Env 5MUT-3fill SOSIP Deposited 2025-09-30 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 509–661(153 aa)
Chain E 32–510(479 aa)
Chain F 32–510(479 aa)
Chain G 32–510(479 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 45 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;150 mM NaCl, 20 mM Tris-HCl, pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.00 Å
9YHR AJ09-110 Fab in complex with HIV-1 Env 5MUT-3fill SOSIP Deposited 2025-09-30 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 509–661(153 aa)
Chain E 32–510(479 aa)
Chain F 32–510(479 aa)
Chain G 32–510(479 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 42 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;150 mM NaCl, 20 mM Tris-HCl, pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.10 Å
9YHS AM12-340 Fab in complex with HIV-1 Env 5MUT-3fill SOSIP Deposited 2025-09-30 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 509–661(153 aa)
Chain E 32–510(479 aa)
Chain F 32–510(479 aa)
Chain G 32–510(479 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY mmCIF provides none of the parsed conditions Resolution 4.30 Å
9YHT AM12-347 Fab in complex with HIV-1 Env 5MUT-3fill SOSIP Deposited 2025-09-30 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 509–661(153 aa)
Chain E 32–510(479 aa)
Chain F 32–510(479 aa)
Chain G 32–510(479 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 24 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;150 mM NaCl, 20 mM Tris-HCl, pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.30 Å
9YIB AM12-351 Fab in complex with HIV-1 Env 5MUT-3fill SOSIP Deposited 2025-10-01 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 509–661(153 aa)
Chain E 32–510(479 aa)
Chain F 32–510(479 aa)
Chain G 32–510(479 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 30 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;150 mM NaCl, 20 mM Tris-HCl, pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.30 Å
9YID AM12-352 Fab in complex with HIV-1 Env 5MUT-3fill SOSIP Deposited 2025-10-01 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 509–661(153 aa)
Chain E 32–510(479 aa)
Chain F 32–510(479 aa)
Chain G 32–510(479 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 30 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;150 mM NaCl, 20 mM Tris-HCl, pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.50 Å
9YIE NN39-25 Fab in complex with HIV-1 Env 5MUT-3fill SOSIP Deposited 2025-10-01 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 509–661(153 aa)
Chain E 32–510(479 aa)
Chain F 32–510(479 aa)
Chain G 32–510(479 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 33 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;150 mM NaCl, 20 mM Tris-HCl, pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.30 Å
9YIF NN39-171 Fab in complex with HIV-1 Env 5MUT-3fill SOSIP Deposited 2025-10-01 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 509–661(153 aa)
Chain E 32–510(479 aa)
Chain F 32–510(479 aa)
Chain G 32–510(479 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 42 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;150 mM NaCl, 20 mM Tris-HCl, pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.80 Å
9YIG V634-136 Fab in complex with HIV-1 Env 5MUT-3fill SOSIP Deposited 2025-10-01 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 509–661(153 aa)
Chain E 32–510(479 aa)
Chain F 32–510(479 aa)
Chain G 32–510(479 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 48 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;150 mM NaCl, 20 mM Tris-HCl, pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.40 Å
9YIH V634-136 UCA Fab in complex with HIV-1 Env del4-3fill SOSIP Deposited 2025-10-01 Assembly 1 Other combination Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 509–661(153 aa)
Chain E 32–510(479 aa)
Chain F 32–510(479 aa)
Chain G 32–510(479 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 33 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;150 mM NaCl, 20 mM Tris-HCl, pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.20 Å
9YII V645-158 Fab in complex with HIV-1 Env 5MUT-3fill SOSIP Deposited 2025-10-01 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 509–661(153 aa)
Chain E 32–510(479 aa)
Chain F 32–510(479 aa)
Chain G 32–510(479 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;150 mM NaCl, 20 mM Tris-HCl, pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.20 Å
9YIJ HIV-1 Env 5MUT-3fill SOSIP Deposited 2025-10-01 Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 509–661(153 aa)
Chain E 32–510(479 aa)
Chain F 32–510(479 aa)
Chain G 32–510(479 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 42 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;150 mM NaCl, 20 mM Tris-HCl, pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.10 Å
9YIK HIV-1 Env del4-3fill SOSIP Deposited 2025-10-01 Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 509–661(153 aa)
Chain E 32–508(477 aa)
Chain F 32–508(477 aa)
Chain G 32–508(477 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 42 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;150 mM NaCl, 20 mM Tris-HCl, pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.90 Å
9YIL HIV-1 Env del8-3fill SOSIP Deposited 2025-10-01 Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain A 509–661(153 aa)
Chain B 509–661(153 aa)
Chain C 509–661(153 aa)
Chain E 32–510(479 aa)
Chain F 32–510(479 aa)
Chain G 32–510(479 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 30 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;150 mM NaCl, 20 mM Tris-HCl, pH 8.0
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 5.00 Å